The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...

A driver reportedly attacked a police officer after trying to do a runner in Stoke-on-Trent. Officers pulled over the dark ...

The Crescent is a 350-home estate, with 181 of the properties being built by Bellway. The £20,000 'incentive' can be added to ...

Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million ...

The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...

Follow live coverage as Norwich City face Stoke City in the Championship today. An increasingly competitive second tier in ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

Norwich City will look to keep their play-off hopes alive when they welcome Stoke City to Carrow Road on Saturday afternoon ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a treatment for Dravet syndrome, a severe form of epilepsy that starts in childhood.